Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.200
+0.040 (1.27%)
Jun 20, 2025, 3:15 PM - Market open
IMDX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 20, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 92 | 40 | 21 | 38 | 200 | 161 | |
| Market Cap Growth | 261.57% | 94.02% | -45.76% | -80.98% | 24.52% | 37.45% | |
| Enterprise Value | 63 | 41 | 14 | 14 | 162 | 159 | |
| Last Close Price | 3.16 | 2.38 | 2.50 | 6.42 | 43.40 | 47.80 | |
| PS Ratio | 14.33 | 21.30 | 13.74 | 39.74 | 91.06 | 132.18 | |
| PB Ratio | 8.84 | -3.26 | 0.81 | 0.96 | 3.07 | 4.80 | |
| P/TBV Ratio | - | - | - | - | - | 17.31 | |
| EV/Sales Ratio | 16.35 | 21.64 | 9.60 | 15.07 | 73.75 | 130.37 | |
| Debt / Equity Ratio | 0.34 | -0.30 | 0.11 | 0.09 | 0.09 | 0.26 | |
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.00 | - | - | - | |
| Asset Turnover | 0.06 | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | |
| Quick Ratio | 3.57 | 1.41 | 1.38 | 1.85 | 2.50 | 0.89 | |
| Current Ratio | 3.75 | 1.62 | 1.49 | 2.11 | 2.77 | 1.03 | |
| Return on Equity (ROE) | -428.96% | -910.86% | -76.26% | -35.52% | -88.37% | -93.07% | |
| Return on Assets (ROA) | -22.17% | -26.42% | -15.91% | -13.88% | -13.82% | -42.66% | |
| Return on Capital (ROIC) | -85.78% | -146.37% | -38.88% | -31.60% | -26.30% | -51.52% | |
| Earnings Yield | -64.47% | -151.40% | -134.52% | -191.48% | -32.03% | -18.62% | |
| FCF Yield | -26.05% | -52.98% | -114.30% | -131.09% | -19.08% | -16.93% | |
| Buyback Yield / Dilution | -111.83% | -70.84% | -38.10% | -24.61% | -35.80% | -27.65% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.